Radiography as primary outcome in rheumatoid arthritis: acceptable sample sizes for trials with 3 months' follow up - PubMed (original) (raw)
Radiography as primary outcome in rheumatoid arthritis: acceptable sample sizes for trials with 3 months' follow up
K Bruynesteyn et al. Ann Rheum Dis. 2004 Nov.
Abstract
Objectives: To investigate whether plain radiographs can show changes in joint damage due to rheumatoid arthritis (RA) within 3 months.
Methods: 188 film pairs taken with a 3 month interval were evaluated. They were scored with (chronological) and without (paired) knowledge of the sequence of the films according to the Sharp/van der Heijde method. Changes in joint damage were analysed on a group and an individual level for different subsets of patients. Sample sizes required to detect statistically and clinically significant differences were estimated based on the percentages of patients with progression larger than the smallest detectable change (SDC).
Results: Changes in joint damage were seen by both the chronological and the paired scoring method. The percentage of patients with progression of joint damage larger than the corresponding SDCs (1.7 and 2.4) varied in the subsets from 18% to 64% if based on the chronological change-scores and from 9% to 36% using paired change-scores. Acceptable sample size estimates were seen in several subsets, depending on (a) how the investigated drug would reduce the individual risk of progression of joint damage (by an absolute or a relative risk reduction model); (b) how damage was scored (chronological or paired); (c) the baseline risk; and (d) whether a two sided or one sided test would be used.
Conclusions: Changes in joint damage due to RA can be detected reliably already within 3 months. This finding can be used to plan short term, randomised controlled trials with radiographic progression as primary outcome.
Similar articles
- Detecting radiological changes in rheumatoid arthritis that are considered important by clinical experts: influence of reading with or without known sequence.
Bruynesteyn K, Van Der Heijde D, Boers M, Saudan A, Peloso P, Paulus H, Houben H, Griffiths B, Edmonds J, Bresnihan B, Boonen A, Van Der Linden S. Bruynesteyn K, et al. J Rheumatol. 2002 Nov;29(11):2306-12. J Rheumatol. 2002. PMID: 12415585 - Measurement error in the assessment of radiographic progression in rheumatoid arthritis (RA) clinical trials: the smallest detectable change (SDC) revisited.
Navarro-Compán V, van der Heijde D, Ahmad HA, Miller CG, Wolterbeek R, Landewé R. Navarro-Compán V, et al. Ann Rheum Dis. 2014 Jun;73(6):1067-70. doi: 10.1136/annrheumdis-2012-202939. Epub 2013 Apr 20. Ann Rheum Dis. 2014. PMID: 23606704 - [Does parenteral gold inhibit roentgen progression of chronic polyarthritis?].
Rau R. Rau R. Z Rheumatol. 1996 Sep-Oct;55(5):307-18. Z Rheumatol. 1996. PMID: 9036717 Review. German. - Radiographic measures to assess patients with rheumatoid arthritis: advantages and limitations.
Yazici Y, Sokka T, Pincus T. Yazici Y, et al. Rheum Dis Clin North Am. 2009 Nov;35(4):723-9, vi. doi: 10.1016/j.rdc.2009.10.005. Rheum Dis Clin North Am. 2009. PMID: 19962616 Review.
Cited by
- Development of the Crohn's disease digestive damage score, the Lémann score.
Pariente B, Cosnes J, Danese S, Sandborn WJ, Lewin M, Fletcher JG, Chowers Y, D'Haens G, Feagan BG, Hibi T, Hommes DW, Irvine EJ, Kamm MA, Loftus EV Jr, Louis E, Michetti P, Munkholm P, Oresland T, Panés J, Peyrin-Biroulet L, Reinisch W, Sands BE, Schoelmerich J, Schreiber S, Tilg H, Travis S, van Assche G, Vecchi M, Mary JY, Colombel JF, Lémann M. Pariente B, et al. Inflamm Bowel Dis. 2011 Jun;17(6):1415-22. doi: 10.1002/ibd.21506. Epub 2010 Nov 28. Inflamm Bowel Dis. 2011. PMID: 21560202 Free PMC article. - EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT).
Combe B, Landewe R, Lukas C, Bolosiu HD, Breedveld F, Dougados M, Emery P, Ferraccioli G, Hazes JM, Klareskog L, Machold K, Martin-Mola E, Nielsen H, Silman A, Smolen J, Yazici H. Combe B, et al. Ann Rheum Dis. 2007 Jan;66(1):34-45. doi: 10.1136/ard.2005.044354. Epub 2006 Jan 5. Ann Rheum Dis. 2007. PMID: 16396980 Free PMC article. - Magnetic resonance imaging of the hand and wrist in a randomized, double-blind, multicenter, placebo-controlled trial of infliximab for rheumatoid arthritis: Comparison of dynamic contrast enhanced assessments with semi-quantitative scoring.
Beals C, Baumgartner R, Peterfy C, Balanescu A, Mirea G, Harabagiu A, Popa S, Cheng A, Feng D, Ashton E, DiCarlo J, Vallee MH, Dardzinski BJ. Beals C, et al. PLoS One. 2017 Dec 13;12(12):e0187397. doi: 10.1371/journal.pone.0187397. eCollection 2017. PLoS One. 2017. PMID: 29236711 Free PMC article. Clinical Trial. - Presentation and analysis of radiographic data in clinical trials and observational studies.
Landewé R, van der Heijde D. Landewé R, et al. Ann Rheum Dis. 2005 Nov;64 Suppl 4(Suppl 4):iv48-51. doi: 10.1136/ard.2005.042572. Ann Rheum Dis. 2005. PMID: 16239387 Free PMC article. Review. - Treating rheumatoid arthritis to target: recommendations of an international task force.
Smolen JS, Aletaha D, Bijlsma JW, Breedveld FC, Boumpas D, Burmester G, Combe B, Cutolo M, de Wit M, Dougados M, Emery P, Gibofsky A, Gomez-Reino JJ, Haraoui B, Kalden J, Keystone EC, Kvien TK, McInnes I, Martin-Mola E, Montecucco C, Schoels M, van der Heijde D; T2T Expert Committee. Smolen JS, et al. Ann Rheum Dis. 2010 Apr;69(4):631-7. doi: 10.1136/ard.2009.123919. Epub 2010 Mar 9. Ann Rheum Dis. 2010. PMID: 20215140 Free PMC article.
References
- Arthritis Rheum. 2001 Oct;44(10):2242-6 - PubMed
- Arthritis Rheum. 2002 Apr 15;47(2):215-8 - PubMed
- J Clin Epidemiol. 2001 Feb;54(2):109-10 - PubMed
- N Engl J Med. 2000 Nov 30;343(22):1594-602 - PubMed
- N Engl J Med. 2000 Nov 30;343(22):1586-93 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical